BEST QUALITY RESEARCH INC
HIALEAH, FLORIDA

Best Quality Research Inc. is a privately owned contract research organization (CRO) established in January 2012, providing specialized clinical research services to the pharmaceutical and biotechnology industries. Operating primarily from Hialeah, Florida, the company facilitates Phase II through IV clinical endpoint studies across various treatment delivery systems including topical transdermal, nasal, inhaled, rectal, vaginal, and intravenous routes. With an emphasis on ensuring studies are executed accurately by experienced staff within a professional environment, Best Quality Research has performed over 200 phases annually, focusing on advancing medical knowledge and helping usher new therapies to market for public benefit. Specializing in early-phase clinical research, the company is committed to high-quality data management, statistical analysis, and reporting services. It operates under strict regulatory compliance in nonclinical drug development aiming to identify promising drug candidates with potential success while rigorously assessing safety profiles. Research studies are conducted under specialist physicians' supervision, seeking volunteers for ongoing trials. Best Quality Research has maintained a robust track record of assisting trial management encompassing CRO negotiations, study start-up activities, recruitment, budget considerations, and document review processes. The organization's dedication to effective and proactive service delivery highlights its reputation within the clinical research community. Key officers such as Abner Castro Ramirez (Vice President) and Ivan B Ferrer (President) lead operations, overseeing the company's strategic direction in Florida with an incorporation status that reflects sound corporate governance. For contact, Best Quality Research can be reached at 2387 W 68 ST, Hialeah, FL, or through their official website at bestqualityresearch.com. The organization was last amended on September 23, 2022, and filed its Annual Report for 2024 as of February 1, 2024.